158 related articles for article (PubMed ID: 19508501)
1. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence--remission sensoring of skin tumours: preliminary results.
Wollina U; Nelskamp C; Scheibe A; Fassler D; Schmidt WD
Skin Res Technol; 2007 Nov; 13(4):463-71. PubMed ID: 17908200
[TBL] [Abstract][Full Text] [Related]
3. Detection of anthralin in skin during treatment.
Juhlin L; Schroot B
Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
[TBL] [Abstract][Full Text] [Related]
4. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Schauder S; Mahrle G
Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
Göransson A
Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
Wollina U; Klinger R; Wetzker R; Knopf B
Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
[TBL] [Abstract][Full Text] [Related]
8. Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis.
Suh DH; Kwon TE; Kim SD; Park SB; Kwon OS; Eun HC; Youn JI
J Am Acad Dermatol; 2001 Jun; 44(6):987-94. PubMed ID: 11369911
[TBL] [Abstract][Full Text] [Related]
9. Anthralin minute entire skin treatment. A new outpatient therapy for psoriasis.
Schwarz T; Gschnait F
Arch Dermatol; 1985 Dec; 121(12):1512-5. PubMed ID: 4062332
[TBL] [Abstract][Full Text] [Related]
10. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline].
Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H
Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597
[No Abstract] [Full Text] [Related]
11. [Combined 1-hour therapy of psoriasis using anthralin and UV light].
Schauder S; Mahrle G
Hautarzt; 1982 Apr; 33(4):206-9. PubMed ID: 7096083
[TBL] [Abstract][Full Text] [Related]
12. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
13. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Remitz A
Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue.
Staberg B; Roed-Petersen J; Menné T
Acta Derm Venereol; 1989; 69(2):147-50. PubMed ID: 2564233
[TBL] [Abstract][Full Text] [Related]
15. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
Schallreuter KU; Pittelkow MR
Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
[TBL] [Abstract][Full Text] [Related]
16. Serum level of sELAM-1 in psoriatic patients correlates with disease activity.
Krasowska D; Pietrzak A; Lecewicz-Torun B
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):140-2. PubMed ID: 10343943
[TBL] [Abstract][Full Text] [Related]
17. [Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
Puschmann M
Z Hautkr; 1983 Nov; 58(22):1646-7. PubMed ID: 6659639
[TBL] [Abstract][Full Text] [Related]
18. A topical treatment program for psoriasis with low anthralin concentrations.
Brody I; Johansson A
J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
[TBL] [Abstract][Full Text] [Related]
19. [Ambulatory external treatment of psoriasis vulgaris: comparison of the effectiveness of a dithranol and a glucocorticoid-containing preparation].
Przybilla B; Kaudewitz P
Z Hautkr; 1988 Jan; 63(1):60-2. PubMed ID: 3281386
[TBL] [Abstract][Full Text] [Related]
20. [White blood cell picture of the peripheral blood of psoriatic patients treated with PUVA and cignoline].
Seneczko F; Kaszuba A
Pol Merkur Lekarski; 1997 Jan; 2(9):165-71. PubMed ID: 10907019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
